About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00659100

A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment

The purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (O...

Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.•35 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age of 18 years or older with symptoms of sleeplessness
•Provided informed consent

Exclusion Criteria

•Contraindications to use of gabapentin

Related studies

WITHDRAWNPhase 3

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

NCT03338764 · Transient Insomnia

COMPLETEDPhase 3

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

NCT00666770 · Transient Insomnia

COMPLETEDPhase 3

A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

NCT00163046 · Transient Insomnia

Not Yet RecruitingPhase 2

SM-1 vs. an Active Comparator in A Model of Transient Insomnia

NCT04396327 · Transient Insomnia

COMPLETEDPhase 3

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

NCT03331042 · Transient Insomnia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment1,254

Start dateAug 2006

Last updatedFeb 2, 2021

Condition

Transient Insomnia

Locations shown

Pfizer Investigational Site

Anaheim, California

Pfizer Investigational Site

Bonita, California

Pfizer Investigational Site

Fallbrook, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions